News

Article June 6, 2022

5 Questions with Elle Lett

Get to know one of the panelists from the 2022 Out in Science event

Profile Diversity

Gladstone in the News May 29, 2022

Fever, Body Aches, Loss of Smell: New COVID Study Charts Evolution of Symptoms

San Francisco Chronicle—A study in the Mission District of San Francisco tracked how COVID-19 symptoms have changed over the course of the pandemic. Gladstone virologist Nadia Roan explains that the Omicron variant infects the upper respiratory tract and triggers a localized immune response, which may in part explain why individuals infected during the Omicron wave were less likely to experience severe illness.

Gladstone Experts COVID-19 Infectious Disease Roan Lab

Gladstone in the News May 28, 2022

Covid Was Vanishing Last Memorial Day. Cases Are Five Times Higher Now.

Washington Post—Even as COVID restrictions are easing, case numbers are rising around the country. Melanie Ott, director of the Gladstone Institute of Virology, explains that recent research from her group shows that individuals infected with the Omicron variant have limited natural immunity, and may still be susceptible to infection with Omicron subvariants.

Gladstone Experts COVID-19 Infectious Disease Ott Lab

Gladstone in the News May 20, 2022

Scientists Explain Why Getting Infected With Omicron Doesn’t Protect You From Other COVID Variants

ABC News—Gladstone virologists investigated the effect of the Omicron variant on the immune response. Melanie Ott describes her team’s discovery that previous infection with Omicron does not result in strong immunity to other known SARS-CoV-2 variants. However, as Nadia Roan explains, individuals who were vaccinated before becoming infected with Omicron did have a broadly protective immune response, emphasizing the importance of the vaccines in saving lives.

Gladstone Experts COVID-19 Infectious Disease Doudna Lab Greene Lab Ott Lab Roan Lab

Gladstone in the News May 18, 2022

UCSF Awarded $67.5 Million to Develop New Antiviral Therapies

UCSF News—Nevan Krogan, PhD, a senior investigator at Gladstone and the director of the Quantitative Biosciences Institute at UC San Francisco, leads a vast, international collaborative effort to find drugs against COVID-19 called the QBI Coronavirus Research Group (QCRG). The group recently received $67.5 million from the National Institutes of Health, the largest such award in UCSF's history, to pursue work on coronaviruses and other viruses with pandemic potential.

Gladstone Experts COVID-19 Data Science and Biotechnology Krogan Lab

Gladstone in the News May 18, 2022

It’s Happening Again: COVID-19 Cases Are Back on the Rise. There Are 3 Main Reasons Why.

USA Today—When the Omicron variant of SARS-CoV-2 swept the country this winter, many had hoped it might help move the population closer to herd immunity. However, Director of the Gladstone Institute of Virology Melanie Ott describes her team’s research that shows that previous infection with Omicron does not provide strong protection against infection with other variants.

Gladstone Experts COVID-19 Infectious Disease Ott Lab

Article May 18, 2022

“Natural Immunity” from Omicron is Weak and Limited, Study Finds

Without vaccination, infection with Omicron fails to confer robust immunity against other COVID-19 variants

News Release Research (Publication) COVID-19 Infectious Disease Doudna Lab Ott Lab Roan Lab

Video May 17, 2022

How to Negotiate Your Industry Job Offer

Gain the skills you need to find a job in industry

Postdoctoral and Graduate Student Education and Research Development Affairs Graduate Organization GO Postdoc Advisory Committee Graduate Students and Postdocs

Article May 16, 2022

Meet Gladstone: Hannah Watry

Hannah Watry shares her love of tap dancing and why she decided to launch RA Appreciation Week at Gladstone

Research Associates Committee Profile Conklin Lab

Gladstone in the News May 12, 2022

Bay Area Scientists Explain the Chances of COVID Reinfections as Omicron Subvariants Spread

ABC News—COVID-19 case numbers are rising in the San Francisco Bay Area, driven by sublineages of the Omicron variant. Gladstone virologist Warner Greene explains that the new subvariants are more infectious, and can evade the antibodies produced in response to vaccination and previous infection.

Gladstone Experts COVID-19 Infectious Disease Greene Lab

Gladstone in the News May 12, 2022

What the Current Spike in Covid-19 Cases Could Say About the Coronavirus’ Future

STAT News—COVID-19 case numbers are rising once again across the United States. Melanie Ott, director of the Gladstone Institute of Virology, explains that the virus is adapting to a new immune landscape, with variants emerging that are able to cause infection even in individuals who were previously infected.

Gladstone Experts COVID-19 Infectious Disease Ott Lab

Article May 12, 2022

Throwing Drug Resistance for a Loop

New class of resistance-proof drugs could one day transform treatments for viral diseases

News Release Research (Publication) Center for Cell Circuitry Infectious Disease Weinberger Lab Chaturvedi

Article May 10, 2022

“City Views” Sale Will Lead to New Mentoring, Training Opportunities

Gladstone auctions off a painting to create a new fund that will support postdoctoral scholars

History Institutional News

Article May 5, 2022

Juggling Motherhood and Science

Here’s what five mothers in STEM have to say about how organizations can better support them

Diversity Profile Womens Initiative

Article April 27, 2022

Zeroing in on a New Treatment for Autism and Epilepsy

Gladstone scientists show that reducing levels of the protein tau soon after birth can prevent these conditions in an experimental model

News Release Research (Publication) Epilepsy Neurological Disease Mucke Lab